Rep. Matsui Introduces Bipartisan Legislation to Support Access to Evidence-Based Care for Rare Disease Patients
December 08, 2021
December 08, 2021
WASHINGTON, Dec. 8 -- Rep. Doris O. Matsui, D-California, issued the following news release:
Congresswoman Doris Matsui (D-CA) and Reps. Mike Thompson (D-CA), Mike Kelly (R-PA), and Markwayne Mullin (R-OK) introduced the Access to Rare Indications Act of 2021, legislation to support patients with rare and ultra-rare diseases in getting evidence-based, medically necessary care covered by their health insurance.
Over 90% of rare diseases have no FDA-approved treatment, le . . .
Congresswoman Doris Matsui (D-CA) and Reps. Mike Thompson (D-CA), Mike Kelly (R-PA), and Markwayne Mullin (R-OK) introduced the Access to Rare Indications Act of 2021, legislation to support patients with rare and ultra-rare diseases in getting evidence-based, medically necessary care covered by their health insurance.
Over 90% of rare diseases have no FDA-approved treatment, le . . .